Research workbench
Acyl transferase from Bacillaene PKS
Analyse Acyl transferase from Bacillaene PKS in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 5DZ6
- Type
- protein
- Length
- 288 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v2 / PDB Bank
- Contract
- 0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
- Owner
- 0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
- Resolution
- 1.44
- Source
- Bacillus subtilis (strain 168)
- Molecule
- Polyketide biosynthesis malonyl CoA-acyl carrier protein transacylase PksC
- EC
- 2.3.1.39
- UniProt
- O34825
- Ligands
- BR, CL
- Pockets
- 1 · best druggability 0.66
Structure
x-ray diffraction · resolution 1.44 · 1 distinct chain · 51% helix, 15% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Polyketide biosynthesis malonyl CoA-acyl carrier protein transacylase PksC (EC 2.3.1.39) | protein | 288 | 51% helix, 15% strand | O34825 |
Ligands and binding sites
- BR · Bromide ion · ion · 2 copies · chains A
- CL · Chloride ion · ion · 2 copies · chains A
- GOL · Glycerol · additive · chains A
- EDO · 1,2-ethanediol · additive · chains A
- PEG · Di(hydroxyethyl)ether · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 287 | 0.66 | 0.82 | 44 | GOL, CL |
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O34825
- Elsewhere: RCSB PDB 5DZ6 · PDBe 5DZ6 · UniProt O34825
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.